US 12,448,357 B1
Amino acid compositions
Ronald Kramer, Signal Hill, CA (US); and Alexandros Nikolaidis, Nea Kallikratia (GR)
Assigned to ThermoLife International, LLC, Signal Hill, CA (US)
Filed by ThermoLife International, LLC, Signal Hill, CA (US)
Filed on Jun. 17, 2024, as Appl. No. 18/745,858.
Application 17/522,680 is a division of application No. 14/621,738, filed on Feb. 13, 2015, granted, now 11,166,979, issued on Nov. 9, 2021.
Application 18/745,858 is a continuation of application No. 17/522,680, filed on Nov. 9, 2021.
Application 14/621,738 is a continuation of application No. 13/920,066, filed on Jun. 17, 2013, granted, now 8,957,100, issued on Feb. 17, 2015.
Application 13/920,066 is a continuation of application No. 13/038,615, filed on Mar. 2, 2011, granted, now 8,466,187, issued on Jun. 18, 2013.
Application 13/038,615 is a continuation in part of application No. 12/336,938, filed on Dec. 17, 2008, granted, now 8,034,836, issued on Oct. 11, 2011.
Application 12/336,938 is a continuation of application No. 11/950,273, filed on Dec. 4, 2007, granted, now 7,777,074, issued on Aug. 17, 2010.
Claims priority of provisional application 60/973,229, filed on Sep. 18, 2007.
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 233/64 (2006.01); A61K 31/185 (2006.01); A61K 31/197 (2006.01); A61K 31/198 (2006.01); A61K 31/205 (2006.01); A61K 31/221 (2006.01); A61K 31/401 (2006.01); A61K 31/4172 (2006.01); A61K 33/00 (2006.01); C07C 229/08 (2006.01); C07C 229/24 (2006.01); C07C 229/26 (2006.01); C07C 237/06 (2006.01); C07C 275/16 (2006.01); C07C 279/02 (2006.01); C07C 323/58 (2006.01); C07D 207/16 (2006.01)
CPC C07D 233/64 (2013.01) [A61K 31/185 (2013.01); A61K 31/197 (2013.01); A61K 31/198 (2013.01); A61K 31/205 (2013.01); A61K 31/221 (2013.01); A61K 31/401 (2013.01); A61K 31/4172 (2013.01); A61K 33/00 (2013.01); C07C 229/08 (2013.01); C07C 229/24 (2013.01); C07C 229/26 (2013.01); C07C 237/06 (2013.01); C07C 275/16 (2013.01); C07C 279/02 (2013.01); C07C 323/58 (2013.01); C07D 207/16 (2013.01)] 24 Claims
 
1. A method of providing an amino acid with faster onset of action to a human subject, the method comprising orally administering the amino acid in the form of a nitrate salt, wherein the nitrate salt form of the amino acid is faster acting compared to other forms of the amino acid.